Synovus Financial (SNV)
(Delayed Data from NYSE)
$40.34 USD
-0.61 (-1.49%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $40.38 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
SNV 40.34 -0.61(-1.49%)
Will SNV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SNV
Synovus' (SNV) Organic Expansion Drives Growth, High Costs Ail
Synovus (SNV) Arm Ratings Affirmed by Moody's, Outlook Stable
SNV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Synovus (SNV) to Sell RWA & Reposition Securities Portfolio
Synovus (SNV) Q1 Earnings & Revenues Miss, Expenses Rise Y/Y
Compared to Estimates, Synovus (SNV) Q1 Earnings: A Look at Key Metrics
Other News for SNV
Synovus price target raised by $1 at JPMorgan, here's why
American Coastal Insurance Corporation Announces a Five-Year Extension of Its Exclusive MGA Agreement With AmRisc and the Election of Two New Directors to Its Insurance Subsidiary
Synovus raised at Barclays after work to strengthen capital, earnings nearly done
Synovus: Strengthened Balance Sheet and Positive Growth Trajectory Justify Buy Rating
Synovus just upgraded at Barclays, here's why